Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 2, 2021
Risk factors for enterococcal urinary tract infections: a multinational, retrospective cohort studyAdi Turjeman, Tanya Babich, Miquel Pujol, et al.
Gene: X|June 19, 2020
Evaluating methods for Avian avulavirus-1 whole genome sequencingSaar Tal, Meirav Ben Izhak, Chaim Wachtel, et al.
Gene|September 17, 2021
Evaluating methods for Avian avulavirus-1 whole genome sequencingSaar Tal, Meirav Ben Izhak, Chaim Wachtel, et al.
Molecular Psychiatry|April 5, 2025
Maternal prenatal stress induces sex-dependent changes in tRNA fragment families and cholinergic pathways in newbornsShani Vaknine Treidel, Silvia M Lobmaier, Ritika Sharma, et al.
Open Forum Infectious Diseases|May 26, 2022
A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream InfectionJessica Howard-Anderson, Weixiao Dai, Dafna Yahav, et al.
JAMA|May 1, 2018
Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical TrialAngela Huttner, Anna Kowalczyk, Adi Turjeman, et al.
Plos One|November 17, 2021
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort studyAdi Turjeman, Fidi Koppel, Erica Franceschini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2018
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled TrialDafna Yahav, Erica Franceschini, Fidi Koppel, et al.
Gerontology|October 23, 2022
External Validity of a Randomized Controlled Trial on Duration of Antibiotics for the Treatment of Gram-Negative BacteremiaAdi Turjeman, Fidi Koppel, Erica Franceschini, et al.
BMC Infectious Diseases|April 1, 2021
Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validityVered Daitch, Mical Paul, George L Daikos, et al.
Pageof 4